Emerson raises bid for Rockwell Automation to $29bn

By Pouyan Broukhim
Share

Rockwell Automation is once again considering a multi-billion-dollar takeover bid, with industry rival Emerson having upped its offer from $27.6bn to $29bn.

Rockwell Automation rejected Emerson’s initial acquisition offer some two weeks back, stating that the offer undervalued the company.

See also:

“We remain convinced there is compelling strategic, operational, and financial merit to bringing together our two companies – and that such a combination would benefit our respective customers, employees and shareholders,” said David Farr, CEO of Emerson.

“The industrial logic for this combination is clear. A combination of Emerson and Rockwell would create a leader in the $200 billion global automation market.”

Rockwell’s shares were up 7%, trading at $202 before the offer was made. However, this remained well below the new offer price that would see Emerson purchasing the entirety of Rockwell’s shares at a price of $225 per share.

Further, the offer represents a 30% premium of Rockwell’s share price prior to any knowledge of Emerson’s proposed acquisition being revealed.

The proposal stands as a part-cash, part-share transaction, with shareholders expected to receive $135 in cash and $90 in Emerson shares per Rockwell share, should the offer be accepted.

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy